PL2935274T3 - Pochodne 3-okso-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pirymidyny do leczenia chorób układu oddechowego - Google Patents
Pochodne 3-okso-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pirymidyny do leczenia chorób układu oddechowegoInfo
- Publication number
- PL2935274T3 PL2935274T3 PL13826565T PL13826565T PL2935274T3 PL 2935274 T3 PL2935274 T3 PL 2935274T3 PL 13826565 T PL13826565 T PL 13826565T PL 13826565 T PL13826565 T PL 13826565T PL 2935274 T3 PL2935274 T3 PL 2935274T3
- Authority
- PL
- Poland
- Prior art keywords
- triazolo
- tetrahydro
- oxo
- treatment
- respiratory diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
- C07C309/08—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/20—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
- C07C47/19—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/02—Formic acid
- C07C53/06—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12197767 | 2012-12-18 | ||
| EP13158757 | 2013-03-12 | ||
| PCT/EP2013/076672 WO2014095700A1 (en) | 2012-12-18 | 2013-12-16 | Novel compounds |
| EP13826565.7A EP2935274B1 (en) | 2012-12-18 | 2013-12-16 | 3-oxo-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidine derivatives for the treatmetn of respiratory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2935274T3 true PL2935274T3 (pl) | 2019-04-30 |
Family
ID=50030225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13826565T PL2935274T3 (pl) | 2012-12-18 | 2013-12-16 | Pochodne 3-okso-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pirymidyny do leczenia chorób układu oddechowego |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US9365577B2 (pl) |
| EP (1) | EP2935274B1 (pl) |
| JP (1) | JP6390919B2 (pl) |
| KR (1) | KR102197721B1 (pl) |
| CN (1) | CN104870449B (pl) |
| AU (1) | AU2013363783B2 (pl) |
| BR (1) | BR112015014438B1 (pl) |
| CA (1) | CA2895352C (pl) |
| CL (1) | CL2015001678A1 (pl) |
| CY (1) | CY1122368T1 (pl) |
| DK (1) | DK2935274T3 (pl) |
| EA (1) | EA028507B1 (pl) |
| ES (1) | ES2700226T3 (pl) |
| GE (2) | GEP20186885B (pl) |
| HR (1) | HRP20182007T1 (pl) |
| IL (1) | IL239447B (pl) |
| LT (1) | LT2935274T (pl) |
| MX (1) | MX2015007379A (pl) |
| NZ (1) | NZ709153A (pl) |
| PE (1) | PE20151084A1 (pl) |
| PH (1) | PH12015501043A1 (pl) |
| PL (1) | PL2935274T3 (pl) |
| PT (1) | PT2935274T (pl) |
| RS (1) | RS58129B1 (pl) |
| SA (1) | SA515360612B1 (pl) |
| SG (2) | SG10201703484YA (pl) |
| SI (1) | SI2935274T1 (pl) |
| TN (1) | TN2015000276A1 (pl) |
| TW (1) | TWI675837B (pl) |
| UA (1) | UA118021C2 (pl) |
| WO (1) | WO2014095700A1 (pl) |
| ZA (1) | ZA201504331B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
| TW201517906A (zh) | 2013-07-25 | 2015-05-16 | Almirall Sa | 含有ｍａｂａ化合物和皮質類固醇之組合 |
| RU2016123379A (ru) * | 2013-12-16 | 2017-12-19 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Тетрагидротриазолопиримидиновые соединения в качестве ингибиторов нейтрофильной эластазы человека |
| US9487528B2 (en) | 2014-06-09 | 2016-11-08 | Chiesi Farmaceutici S.P.A. | Compounds |
| KR20170016840A (ko) * | 2014-06-12 | 2017-02-14 | 키에시 파르마슈티시 엣스. 피. 에이. | 신규화합물 |
| US9657015B2 (en) | 2014-07-31 | 2017-05-23 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
| US9475779B2 (en) | 2014-07-31 | 2016-10-25 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
| TW201617343A (zh) | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物 |
| AR106958A1 (es) | 2015-12-14 | 2018-03-07 | Chiesi Farm Spa | Derivados de tetrahidrotriazolopirimidina útiles como inhibidores de hne |
| WO2017207433A1 (en) | 2016-05-31 | 2017-12-07 | Chiesi Farmaceutici S.P.A. | Hetetocyclic compounds for use in the treatment of a disease in which hne is implicated |
| EP3464268B1 (en) | 2016-05-31 | 2020-03-11 | Chiesi Farmaceutici S.p.A. | Novel compounds |
| EA036456B1 (ru) | 2016-05-31 | 2020-11-12 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Имидазолиновые соединения в качестве ингибиторов эластазы нейтрофилов человека |
| AU2019373948B2 (en) | 2018-10-30 | 2023-11-16 | Chiesi Farmaceutici S.P.A. | Apparatus to administer drugs to mechanically ventilated patients |
| CN114514020A (zh) | 2019-09-24 | 2022-05-17 | 奇斯药制品公司 | 用于吸入用干粉制剂的新型载体颗粒 |
| EP4452980A1 (en) | 2021-12-22 | 2024-10-30 | Chiesi Farmaceutici S.p.A. | Triazolone derivative salt as neutrophil elastase inhibitor |
| JP2025501748A (ja) | 2021-12-22 | 2025-01-23 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | 好中球エラスターゼ阻害剤としてのトリアゾロン誘導体塩 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
| EA001437B1 (ru) * | 1996-03-28 | 2001-02-26 | Глаксо Груп Лимитед | Производные пирролопирролона в качестве ингибиторов нейтрофильной эластазы |
| GB0608844D0 (en) * | 2006-05-04 | 2006-06-14 | Argenta Discovery Ltd | Enzyme inhibitors |
| DE102009004197A1 (de) * | 2009-01-09 | 2010-07-15 | Bayer Schering Pharma Aktiengesellschaft | Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung |
| GB201004179D0 (en) * | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
| GB201004178D0 (en) * | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
| TWI568735B (zh) * | 2011-09-14 | 2017-02-01 | 吉斯藥品公司 | 新穎化合物 |
-
2013
- 2013-12-16 PT PT13826565T patent/PT2935274T/pt unknown
- 2013-12-16 CA CA2895352A patent/CA2895352C/en active Active
- 2013-12-16 GE GEAP201313860A patent/GEP20186885B/en unknown
- 2013-12-16 SI SI201331244T patent/SI2935274T1/sl unknown
- 2013-12-16 LT LTEP13826565.7T patent/LT2935274T/lt unknown
- 2013-12-16 RS RS20181517A patent/RS58129B1/sr unknown
- 2013-12-16 EA EA201590962A patent/EA028507B1/ru unknown
- 2013-12-16 DK DK13826565.7T patent/DK2935274T3/en active
- 2013-12-16 PE PE2015000931A patent/PE20151084A1/es unknown
- 2013-12-16 KR KR1020157016352A patent/KR102197721B1/ko active Active
- 2013-12-16 CN CN201380065981.1A patent/CN104870449B/zh active Active
- 2013-12-16 ES ES13826565T patent/ES2700226T3/es active Active
- 2013-12-16 MX MX2015007379A patent/MX2015007379A/es active IP Right Grant
- 2013-12-16 TW TW102146370A patent/TWI675837B/zh active
- 2013-12-16 HR HRP20182007TT patent/HRP20182007T1/hr unknown
- 2013-12-16 AU AU2013363783A patent/AU2013363783B2/en active Active
- 2013-12-16 WO PCT/EP2013/076672 patent/WO2014095700A1/en not_active Ceased
- 2013-12-16 NZ NZ709153A patent/NZ709153A/en unknown
- 2013-12-16 JP JP2015547060A patent/JP6390919B2/ja active Active
- 2013-12-16 PL PL13826565T patent/PL2935274T3/pl unknown
- 2013-12-16 EP EP13826565.7A patent/EP2935274B1/en active Active
- 2013-12-16 SG SG10201703484YA patent/SG10201703484YA/en unknown
- 2013-12-16 BR BR112015014438-1A patent/BR112015014438B1/pt active IP Right Grant
- 2013-12-16 SG SG11201504737RA patent/SG11201504737RA/en unknown
- 2013-12-16 GE GEAP201813860A patent/GEAP201813860A/en unknown
- 2013-12-16 UA UAA201505958A patent/UA118021C2/uk unknown
- 2013-12-17 US US14/108,904 patent/US9365577B2/en active Active
-
2015
- 2015-05-11 PH PH12015501043A patent/PH12015501043A1/en unknown
- 2015-06-15 ZA ZA2015/04331A patent/ZA201504331B/en unknown
- 2015-06-16 IL IL239447A patent/IL239447B/en active IP Right Grant
- 2015-06-16 CL CL2015001678A patent/CL2015001678A1/es unknown
- 2015-06-16 TN TNP2015000276A patent/TN2015000276A1/fr unknown
- 2015-06-17 SA SA515360612A patent/SA515360612B1/ar unknown
-
2016
- 2016-05-10 US US15/150,749 patent/US9828382B2/en active Active
-
2018
- 2018-11-07 CY CY20181101168T patent/CY1122368T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20182007T1 (hr) | Derivati 3-okso-2,3,5,8-tetrahidro-[1,2,4]triazolo[4,3-a]pirimidina za liječenje respiratornih bolesti | |
| HUS1900040I1 (hu) | Makrociklusos származékok proliferatív betegségek kezelésére | |
| IL264402B (en) | History of pyrrolo(2,3–d)pyrimidine for the treatment of viral infections and other diseases | |
| IL237761B (en) | History of pyrrolo[2,3–d]pyrimidine for the treatment of viral infections and other diseases | |
| IL235659A0 (en) | History of 3, 4 - dihydro -2h - pyrido [1, 2 - a] pyrazine - 1,2,1] 6 converted diones used to treat (among others) Alzheimer's disease | |
| DK3418281T3 (da) | Pyrazolo[1,5-a]pyrimidiner, der er anvendelige som inhibitorer af atr-kinase til behandling af cancersygdomme | |
| IL246311A0 (en) | Pyrazolo[5,1-a]pyridine derivatives and methods of using them | |
| IL243092B (en) | New triazolo[d–4,5]pyrimidine histories | |
| ZA201406323B (en) | Triazolo[4,5-d]pyrimidine derivatives | |
| HRP20182021T1 (hr) | Derivati [1,2,4]triazolo[1,5-a]pirimidina kao inhibitori proteazoma protozoe za liječenje parazitskih bolesti poput lišmenijaze | |
| PL395469A1 (pl) | Pochodne indoloamin do leczenia chorób osrodkowego ukladu nerwowego |